Katabole Technology Venture

Founder and CEO Balaji Jagannathan heads the firm. The investment committee is effectively the partnership group, which includes directors Jaikumar Vaikam Mani, Venkataraman Gopalakrishnan Govindrajapuram, and Krishna Jagannathan, plus partners Bharat Kailash Banka and Hemant Nerurkar. The presence of a family member in a director role suggests the founder retains significant influence over investment decisions.

Katabole describes itself as an investment company, not a venture capital fund. There is no public record of a regulated fund structure, limited partners, or institutional capital commitments. This likely means the firm invests proprietary or partner capital rather than managing outside LP money with a defined fund life and return targets.

The firm focuses on early-stage transactions, specifically seed and start-up rounds. There is no indication of participation in growth-stage, late-stage, or pre-IPO rounds based on available information. The generalist mandate suggests it evaluates opportunities across sectors at the earliest stages of company formation.

One disclosed co-investment involves Vaishali Rajaram in PurpleHealth, a health-tech company, indicating Katabole does participate in syndicated or co-investment deals alongside other individuals. It is unclear whether the firm regularly partners with institutional venture funds or primarily co-invests with other high-net-worth individuals from its network.

The directorship of Krishna Jagannathan, who shares the founder's surname and is explicitly tagged as a family member in available records, connects the firm to a family governance structure. The investment company may serve as the venture investment vehicle for a broader family office or pooled family capital, though no wealth origin has been publicly disclosed.